{"id":64419,"date":"2025-02-07T00:02:55","date_gmt":"2025-02-07T00:02:55","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/07\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/"},"modified":"2025-02-07T00:02:55","modified_gmt":"2025-02-07T00:02:55","slug":"crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","title":{"rendered":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025"},"content":{"rendered":"<div>\n<p align=\"justify\">SAN DIEGO, Feb.  06, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QNYpDJ-5z26hYVjHN41zTvctIswIJ58agvmwYVVUAMoyDU8-jUXwaXDPyocgKIREhsx8Y8BfXFniHjP6FSyHb9Exw9RlzjQBnrjsC-NhUaDWinsZC1AEEZX7SCh8V1p_VqNvRHoW_55Ox_4yhlJ3j_BFsbMWyPiiwMrVj84roX6CX4i92D17W_FuDjSy5Tc_K7C1MRpaNsKPsp_FwgkUwg==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>Crinetics Pharmaceuticals, Inc.<\/u><\/a> (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update.<\/p>\n<p align=\"justify\"><strong>Conference Call &amp; Webcast<\/strong><\/p>\n<p align=\"justify\"><u>Thursday, February 27 @ 4:30 p.m. ET<\/u><\/p>\n<p align=\"justify\">Domestic: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01-800-267-6316<br \/>International:\u00a0 \u00a0 1-203-518-9783<br \/>Conference ID:\u00a0 CRNXQ4<\/p>\n<p align=\"justify\"><strong>Webcast:<\/strong> Participants can use the dial-in numbers above OR access the live webcast via a direct link (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6yNCRzF0UsBw1rdADFpjCLOVPCMRcGhQwFPjMTbTemDFq70lsy6VJf2IEGiXXrGalbJAJc5cUNa_Ri2h4r8hTJSufqbHoszFNcGE35_JoU6ylBpI7ZQPR9oEeowaRpc2anWYz5Ht09b4c6NoXa6rnQ==\" rel=\"nofollow\" target=\"_blank\" title=\"HERE\">HERE<\/a>) or by visiting the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CBZtGjCi9TBcXlw940H5VVNXslRuksiUHAU7JAFr0x63zCipWdPWVtv7A6Or0Xyg8vktby7Pl2-NrrV7BFONmKjKOr4bnS2zvQhlc9yCP8Z4_yPNsu95vmBlJHExMpDkpKT5A6ecPV-wbb_aBXcI6T729MCJ0fw_HTL_XbwNumf2SvqYylkamDoJD1NnU2-CnkShqfaZ4w2TYKJH-7wdNA==\" rel=\"nofollow\" target=\"_blank\" title=\"Events section\">Events section<\/a> of the Crinetics website. To ensure a timely connection, it is recommended that participants connect at least 15 minutes prior to the scheduled start of the call.<\/p>\n<p align=\"justify\">The webcast will be archived on the Investor Relations section of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K3AHlYhXAMFDUyqQRDYM9JRQRp4daJuTLAXyUuuyrbFM7v0zo_SzNMZYHL3zVA0kuYdZ2LmXTVx5fYSXCZpWrCXAUCXSeDBAolpWTfwZE6E=\" rel=\"nofollow\" target=\"_blank\" title=\"www.crinetics.com\">www.crinetics.com<\/a>.<\/p>\n<p align=\"justify\"><strong>About Crinetics Pharmaceuticals <\/strong><br \/>Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. Crinetics\u2019 lead development candidate,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-S9oSqeD1ES8714xj89EMxHklvSlE4cUpIpYVa7lJ1KhsBjpAuNhhws2CNCict50O1_1YL91fAyeF5eUpXnyk76KPDaFBlKTvBmufMEJKMSpX3xa95nZURNxnhwI8boOlKQDZHcq2T43SPcJpmOQgRccRbHa8ekzOnVVGWi46nE=\" rel=\"nofollow\" target=\"_blank\" title=\"paltusotine\">paltusotine<\/a>, is the first investigational once-daily, oral, selective somatostatin receptor type 2 (SST2) nonpeptide agonist that is in clinical development for acromegaly and carcinoid syndrome associated with neuroendocrine tumors. Atumelnant is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing\u2019s syndrome. All of the company\u2019s drug candidates are orally delivered, small molecule, new chemical entities resulting from in-house drug discovery efforts, including additional discovery programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves\u2019 disease (including thyroid eye disease), diabetes, obesity and GPCR-targeted oncology indications.<\/p>\n<p><strong>Investors:<\/strong><br \/>Gayathri Diwakar<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZAwOaJ5-LxCAZd7GBpGJ8B87xk61Ovb-tgPDBaJAmIsFqAT_jdGfoLukr9sZD8z9TvQOjLcfrxNZwhLe2mxLC4MCH354T3EQq-Anl1GRqGw=\" rel=\"nofollow\" target=\"_blank\" title=\"gdiwakar@crinetics.com\">gdiwakar@crinetics.com<\/a> <br \/>(858) 345-6340<\/p>\n<p><strong>Media:<\/strong> <br \/>Natalie Badillo<br \/>Head of Corporate Communications <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zNEkmc1wW5GeEwtBiUgDmik0o912DdQpbNtRLNclNWqeeH8KUKewBisHGmvaMTZUziEZX3XGKDX2hKNcBTJrHznaZpsnS2nY7C2FaCBxH4M=\" rel=\"nofollow\" target=\"_blank\" title=\"nbadillo@crinetics.com\">nbadillo@crinetics.com<\/a> <br \/>(858) 345-6075<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzY0NmY5ZGYtOWQzMC00YTUxLThlZDYtZDM5MzgyN2Q2YTY1LTExMDEzODY=\/tiny\/Crinetics-Pharmaceuticals-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business [&#8230;]\n","protected":false},"author":1,"featured_media":64420,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter an\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-07T00:02:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Crinetics-Pharmaceuticals-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025\",\"datePublished\":\"2025-02-07T00:02:55+00:00\",\"dateModified\":\"2025-02-07T00:02:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\"},\"wordCount\":290,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\",\"name\":\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-07T00:02:55+00:00\",\"dateModified\":\"2025-02-07T00:02:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","og_locale":"en_US","og_type":"article","og_title":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025","og_description":"SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter an","og_url":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-07T00:02:55+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Crinetics-Pharmaceuticals-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025","datePublished":"2025-02-07T00:02:55+00:00","dateModified":"2025-02-07T00:02:55+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/"},"wordCount":290,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","url":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/","name":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-07T00:02:55+00:00","dateModified":"2025-02-07T00:02:55+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-27-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64419"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64419\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64420"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}